Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

CareDx Expects Q4 Preliminary Revenue Of $65M-$66M, Down Approximately 3% Q/Q; Est. $61.71M

Author: Benzinga Newsdesk | January 09, 2024 08:11am

Preliminary cash, cash equivalents, and marketable securities were approximately $235 million as of December 31, 2023.

Posted In: CDNA

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist